title: Immunological intervention with monoclonal antibodies.
abstract: A recent workshop held in the Bavarian alps considered the possibilities for immunological intervention with monoclonal antibodies. While at present the benefits of most attempts to use monoclonal antibodies in vivo in man are uncertain, in-vitro and animal experiments have yielded enough positive results to encourage further efforts. Immediate dramatic effects are not to be expected because as one participant noted, we are still at an early stage in the use of monoclonal antibodies as therapeutic agents.
authors.affiliation: Peter Beverley is in the ICRF Human Tumour Immunology Group, University College London, UK.
authors.forename: P C
authors.initials: PC
authors.lastname: Beverley
authors.affiliation: G. Riethmuller is at the Institute for Immunology of the University of Munich, FRG.
authors.forename: G
authors.initials: G
authors.lastname: Riethmuller